Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ORGO
ORGO logo

ORGO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ORGO News

Organogenesis Completes PuraPly AM Clinical Trial for Diabetic Foot Ulcers

Apr 07 2026NASDAQ.COM

Organogenesis Shares Surge 29% After Successful Clinical Trial for PuraPlyAM

Apr 07 2026seekingalpha

Organogenesis Completes PuraPly®AM Clinical Trial with Significant Results

Apr 06 2026Newsfilter

Organogenesis Shares Surge After FDA Meeting on ReNu Approval

Apr 06 2026stocktwits

Organogenesis Completes FDA Meeting, Plans BLA Submission

Apr 06 2026Newsfilter

Organogenesis Holdings Inc. to Begin Rolling BLA for Renu After Positive FDA Meeting

Apr 06 2026moomoo

Organogenesis to Report Q1 2026 Financial Results on May 7

Apr 06 2026Newsfilter

Organogenesis Reports Record Q4 2025 Earnings Amid Market Uncertainty

Feb 27 2026seekingalpha

ORGO Events

04/07 12:10
Major Averages Decline as Oil Prices Surpass $117
The major averages were lower near noon, erasing yesterday's gains amid fading hopes of an imminent end to the U.S.-Iran war and oil prices surpassing $117 per barrel. President Trump has established an 8:00 pm ET deadline for the two sides to reach an agreement to reopen the Strait of Hormuz, otherwise the U.S. will attack Iran's power plants and bridges. Trump's recent comments include the president saying on Truth Social, "A whole civilization will die tonight, never to be brought back again. I don't want that to happen, but it probably will."Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:The Centers for Medicare and Medicaid released its 2027 Medicare Advantage payments, with policies project to result in aBroadcomand Alphabetentered into aPershing Square proposed toof Universal Music GroupApple'sfoldable iPhone has encountered setbacks,Organogenesissaid itin its PuraPly study2. WALL STREET CALLS:Armto Equal Weight at Morgan StanleyRosenblattArista Networkson increased confidence in XPO strategyBarringtonFuboTVto Outperform on updated financial outlookCitiWingstopto Buy into potential sales reboundRocket Labto Outperform at Citizens3. AROUND THE WEB:Amazonhas rebuffed requests from its wholesale suppliers for increased payments to cover higher costs, prompting some to pull items from the company's site, Information reportsThe families behind Puig and Estee Lauderare set to meet in New York this week to negotiate the terms of a potential combination of their beauty businesses with the goal of announcing an agreement in the coming weeks, Expansion saysUlta BeautyCEO Kecia Steelman said GLP-1 users are purchasing hair and skincare products to combat the side effects of the weight loss treatments, Business Insiders reportsDelta Air Lineshas hiked its fee for checked bags by $10 for tickets bought starting Wednesday, following similar moves by Unitedand JetBlueamid a surge in jet fuel expenses this year, CNBC saysAnthropic plans to invest $200M in a new venture with private equity firms that looks to sell AI tools to their portfolio companies amid a push for business customers, WSJ reports4. MOVERS:Patterson-UTIgains after reportingn the U.S. in MarchPerrigoincreases in New York after ain Ben Harrington's Betaville blogMach Naturaldeclines after announcing aRedwirelower afterwith a new office in the United KingdomSuzanofalls in New York after BofAthe stock to Neutral5. EARNINGS/GUIDANCE:PrecigenSamsungNeuroneticsfor Q1 and FY26RPM Internationalis expectedon April 8Levi Straussis expectedon April 7INDEXES:Near midday, the Dow was down 0.81%, or 377.95, to 46,291.93, the Nasdaq was down 1.10%, or 241.75, to 21,754.59, and the S&P 500 was down 0.81%, or 53.79, to 6,558.04.
04/06 20:30
Market Sentiment Steady as S&P 500 and Dow Rise
Trump's Tuesday night deadline to "take out" the "entire" country of Iran is looming while Iran's top command - at least publicly - appears to be willing to see through his bluster, calling those threat "delusional".  And yet, investment sentiment has held up through the headline risk for the fourth  straight session.    Markets continued to bounce on Monday following a long-weekend - the S&P 500 and Dow Industrials were up 0.4% while Nasdaq Composite was up 0.5%.  Consumer Staples was the best performing sector in the S&P 500, but other defensive areas such as Health Care and Utilities lagged the "growthier" areas of the market as Financials and Industrials outperformed.  Among the standout names in the benchmark, AppLovin Corporationwas the best performing stock, with traders bottom-fishing on the stock's 39% year-to-date decline.  In turn, this year's winners such as Lumentumand Cienaretreater from their recent highs.   In the evening hours, sentiment is somewhat more subdued - S&P e-minis is down 0.1%, Nasdaq 100 contract is off by 0.2%, while WTI Crude Oil is now breaking a pattern of inverse correlation with equities and also retreating below $113 per barrel.Afterhours, health insurers were notably higher as CMS had finalizes its Medicare payment policy with a 2027 rate increase around 2.5% vs. the 0.1% target that spooked the industry back in January.  Broadcomwas also firmer after announcing an expanded long-term supply agreement for Google's future generations of Tensor Processing Units as well as a broader collaboration with Anthropic.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Owletup 9.2% after above-consensus Q1 pre-announcementALSO HIGHER -Organogenesis Holdingsup 15.2% after announcing it has met primary endpoint in PuraPly studyUnitedHealthup 8.0%, Humanaup 10.7%, Centeneup 4.5%, Molina Healthcareup 3.8%, Elevance Healthup 6.4%, CVS Healthup 6.4% after CMS finalizes Medicare payment policy at higher than expected ratesBroadstone Net Lease, Inc.up 3.4% after admission into S&P SmallCap 600 indexBroadcomup 2.5%  after announcing expanded Google supply pact after announcing broader collaboration with Google and AnthropicPayPayup 1.7% after initiation at Buy at Goldman SachsCasey's General Storesup 1.0% after admission into S&P 500 indexMercadoLibreup 0.7% after being upgraded to Buy at JefferiesLOWER -Mach Natural Resources LPdown 5.2% after equity offering
04/06 19:10
Organogenesis Completes PuraPly(R)AM Clinical Trial
The company states: "Organogenesis Holdings announced the completion of a randomized controlled trial evaluating PuraPly(R)AM plus standard of care versus SOC alone in the management of non-healing diabetic foot ulcers. The prospective, multi-center, randomized controlled trial of 170 patients evaluated the safety and efficacy of PuraPly AM plus SOC. The trial achieved its primary endpoint, demonstrating statistically significant wound closure at 12 weeks, compared to SOC alone. These findings further demonstrate the clinical effectiveness of PuraPly(R)AM in the management of DFUs expanding the body of evidence supporting its use. Organogenesis plans to publish the study results soon in a peer-reviewed journal."

ORGO Monitor News

No data

No data

ORGO Earnings Analysis

No Data

No Data

People Also Watch